Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 3838646, 6 pages
http://dx.doi.org/10.1155/2016/3838646
Research Article

Prenatal and Childhood Growth, Chemerin Concentrations, and Metabolic Health in Adult Life

1National Institute for Health and Welfare, Department of Chronic Disease Prevention, 00271 Helsinki, Finland
2Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland
3Folkhälsan Research Centre, 00250 Helsinki, Finland
4Institute of Biomedicine, Exercise Medicine, University of Eastern Finland, 70211 Kuopio, Finland
5MRC Lifecourse Epidemiology Unit (University of Southampton), Southampton General Hospital, Southampton SO16 6YD, UK

Received 10 October 2015; Revised 5 December 2015; Accepted 16 December 2015

Academic Editor: Kristin Eckardt

Copyright © 2016 Johan G. Eriksson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. P. Barker, C. Osmond, E. Kajantie, and J. G. Eriksson, “Growth and chronic disease: findings in the Helsinki Birth Cohort,” Annals of Human Biology, vol. 36, no. 5, pp. 444–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. G. Eriksson, T. Forsén, J. Tuomilehto, C. Osmond, and D. J. P. Barker, “Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life,” Diabetologia, vol. 46, no. 2, pp. 190–194, 2003. View at Google Scholar · View at Scopus
  3. J. G. Eriksson, C. Osmond, E. Kajantie, T. J. Forsén, and D. J. P. Barker, “Patterns of growth among children who later develop type 2 diabetes or its risk factors,” Diabetologia, vol. 49, no. 12, pp. 2853–2858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. H. D. Fall, H. S. Sachdev, C. Osmond et al., “Adult metabolic syndrome and impaired glucose tolerance are associated with different patterns of BMI gain during infancy: data from the New Delhi Birth Cohort,” Diabetes Care, vol. 31, no. 12, pp. 2349–2356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Godfrey, K. A. Lillycrop, G. C. Burdge, P. D. Gluckman, and M. A. Hanson, “Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease,” Pediatric Research, vol. 61, no. 5, part 2, pp. 5R–10R, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Eriksson, “Early growth and coronary heart disease and type 2 diabetes: findings from the Helsinki Birth Cohort Study (HBCS),” American Journal of Clinical Nutrition, vol. 94, supplement 1, no. 6, pp. 1799S–1802S, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Bozaoglu, K. Bolton, J. McMillan et al., “Chemerin is a novel adipokine associated with obesity and metabolic syndrome,” Endocrinology, vol. 148, no. 10, pp. 4687–4694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Stejskal, M. Karpisek, Z. Hanulova, and M. Svestak, “Chemerin is an independent marker of the metabolic syndrome in a Caucasian population—a pilot study,” Biomedical Papers of the Medical Faculty of Palacký University, Olomouc, Czech Republic, vol. 152, no. 2, pp. 217–221, 2008. View at Google Scholar
  9. K. Bozaoglu, D. Segal, K. A. Shields et al., “Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, pp. 3085–3088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Jialal, S. Devaraj, H. Kaur, B. Adams-Huet, and A. A. Bremer, “Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. E514–E517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Fatima, R. Rehman, M. Baig, and T. A. Khan, “New roles of the multidimensional adipokine: chemerin,” Peptides, vol. 62, pp. 15–20, 2014. View at Publisher · View at Google Scholar
  12. Y. Li, B. Shi, and S. Li, “Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis,” PLoS ONE, vol. 9, no. 12, Article ID e113915, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. WHO, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
  14. A. Kunst, B. Draeger, and J. Ziegenhorn, “UV-methods with hexokinase and glucose-6-phosphate dehydrogenase,” in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 163–172, Verlag Chemie, Weinheim, Germany, 1983. View at Google Scholar
  15. W. J. Sobey, S. F. Beer, C. A. Carrington et al., “Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins,” Biochemical Journal, vol. 260, no. 2, pp. 535–541, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. R. F. Lie, J. M. Schmitz, K. J. Pierre, and N. Gochman, “Cholesterol oxidase based determination, by continuous flow analysis, of total and free cholesterol in serum,” Clinical Chemistry, vol. 22, no. 10, pp. 1627–1630, 1976. View at Google Scholar · View at Scopus
  17. P. Fossati and L. Prencipe, “Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,” Clinical Chemistry, vol. 28, no. 10, pp. 2077–2080, 1982. View at Google Scholar · View at Scopus
  18. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  19. K. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Google Scholar
  20. S. Mazaki-Tovi, M. Kasher-Meron, R. Hemi et al., “Chemerin is present in human cord blood and is positively correlated with birthweight,” American Journal of Obstetrics & Gynecology, vol. 207, no. 5, pp. 412.e1–412.e10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Boutsikou, D. D. Briana, M. Boutsikou et al., “Cord blood chemerin and obestatin levels in large for gestational age infants,” Journal of Maternal Fetal and Neonatal Medicine, vol. 26, no. 2, pp. 123–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Wang, G.-Y. Yuan, X.-Z. Wang et al., “Plasma chemerin level in metabolic syndrome,” Genetics and Molecular Research, vol. 12, no. 4, pp. 5986–5991, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Yang, G. Yang, J. Dong et al., “Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension,” Journal of Investigative Medicine, vol. 58, no. 7, pp. 883–886, 2010. View at Publisher · View at Google Scholar
  24. A. A. Roman, S. D. Parlee, and C. J. Sinal, “Chemerin: a potential endocrine link between obesity and type 2 diabetes,” Endocrine, vol. 42, no. 2, pp. 243–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. J. Hare, L. Bonde, J. A. Svare et al., “Decreased plasma chemerin levels in women with gestational diabetes mellitus,” Diabetic Medicine, vol. 31, no. 8, pp. 936–940, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. B. A. Zabel, S. J. Allen, P. Kulig et al., “Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades,” Journal of Biological Chemistry, vol. 280, no. 41, pp. 34661–34666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Lehrke, A. Becker, M. Greif et al., “Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis,” European Journal of Endocrinology, vol. 161, no. 2, pp. 339–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Weigert, M. Neumeier, J. Wanninger et al., “Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes,” Clinical Endocrinology, vol. 72, no. 3, pp. 342–348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Xiaotao Jr., Z. Xiaoxia, X. Yue, and W. Liye, “Serum chemerin levels are associated with the presence and extent of coronary artery disease,” Coronary Artery Disease, vol. 23, no. 6, pp. 412–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Fülöp, I. Seres, H. Lorincz, M. Harangi, S. Somodi, and G. Paragh, “Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients,” Journal of Cellular and Molecular Medicine, vol. 18, no. 7, pp. 1313–1320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Lőrincz, M. Katkó, M. Harangi et al., “Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects,” Clinical Endocrinology, vol. 81, no. 3, pp. 370–377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. F. Garces, E. Sanchez, B. J. Acosta et al., “Expression and regulation of chemerin during rat pregnancy,” Placenta, vol. 33, no. 5, pp. 373–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Barker, R. Lim, G. E. Rice, and M. Lappas, “Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity,” Journal of Maternal Fetal and Neonatal Medicine, vol. 25, no. 11, pp. 2274–2280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D.-M. Duan, J.-M. Niu, Q. Lei, X.-H. Lin, and X. Chen, “Serum levels of the adipokine chemerin in preeclampsia,” Journal of Perinatal Medicine, vol. 40, no. 2, pp. 121–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Stepan, A. Philipp, I. Roth et al., “Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy,” Regulatory Peptides, vol. 168, no. 1–3, pp. 69–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. K. Tan, J. Chen, S. Farhatullah et al., “Insulin and metformin regulate circulating and adipose tissue chemerin,” Diabetes, vol. 58, no. 9, pp. 1971–1977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Ylihärsilä, E. Kajantie, C. Osmond, T. Forsén, D. J. P. Barker, and J. G. Eriksson, “Body mass index during childhood and adult body composition in men and women aged 56–70 y,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1769–1775, 2008. View at Google Scholar · View at Scopus